Biotechnology News

October 19, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that the Company will host...

October 19, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) today announced that it will shortly initiate a new phase II, proof-of-concept clinical trial with tasquinimod in a so-called umbrella study evaluating the...

October 19, 2012

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that MidCap Financial, LLC ("MidCap" or the “Lender”), pursuant to the amendment to the Loan and Security...

October 18, 2012

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology Announces Upsizing of Public Offering

October 18, 2012

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, will announce the financial results for the third quarter and nine months ended September 30, 2012 after the market close on Thursday,...

October 18, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its third quarter financial results on October 24, 2012 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:...

October 18, 2012

SAN DIEGO--(BUSINESS WIRE)--Durata Therapeutics announced data demonstrating the reliability of the measurement tools deployed in Phase 3 clinical trials of dalbavancin for the treatment of ABSSSI. Data were presented at IDWeek.

October 18, 2012

SAN DIEGO--(BUSINESS WIRE)--Durata Therapeutics today announced in vitro study data that could help support a clinical development program to investigate dalbavancin for the treatment of pneumonia. Data were presented at IDWeek.

October 18, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) announced today that Magistrate Judge Elizabeth D. LaPorte of the U.S. District Court for the Northern District of California granted a motion for summary judgment of invalidity filed by...

October 18, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (Nasdaq:CLVS) will announce its third quarter 2012 financial results on Monday, November 5, 2012, after the close of the U.S. financial markets. Clovis’ senior management will host a...

October 18, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the third quarter ended September 30, 2012. The Company will host a conference call and webcast today at 5:00 p.m. ET (details below)....

October 18, 2012

LOUISVILLE, Ky.--(BUSINESS WIRE)--Leading pharmacogenetics laboratory PGXL announces national distribution joint venture.

October 18, 2012

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall and its leadership team have been instrumental in the shift toward single-use manufacturing in the biopharmaceutical industry. Pall’s Jerold Martin was named Thought Leader of the Decade by BPI.

October 18, 2012

WYNNEWOOD, Pa.--(BUSINESS WIRE)--CD Diagnostics, Inc. completed the purchase of 80% of the outstanding capital stock of Citrano Medical Laboratories, Inc. (CML or Citrano) located in Towson, Maryland.

October 18, 2012

WASHINGTON--(BUSINESS WIRE)--Allied biofuel trade organizations today wrote to Congressional leaders to ask that they support the Renewable Fuel Standard and oppose requests to waive it.

October 18, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) announces registration and housing for the 2013 BIO International Convention is now available. The event will be held April 22-25, 2013 in Chicago, IL.

October 18, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces the signature of an agreement* with...

October 18, 2012

NEW YORK--(BUSINESS WIRE)--Manhattan Research’s Cybercitizen Health® U.S. 2012 study finds over half of online consumers say online information or tools have influenced their health choices

October 18, 2012

WASHINGTON--(BUSINESS WIRE)--BIO President Jim Greenwood delivered a call to arms for the renewable energy community to defend the Renewable Fuel Standard during a keynote speech to ACORE's RETECH 2012 Conference.

October 18, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through 2021, the number of disease-modifying therapies approved for the...

October 18, 2012

VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD) today announced that it has entered into a purchase agreement with The Mann Group LLC, an entity controlled by MannKind’s chief executive officer and principal stockholder,...

October 18, 2012

VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD) today announced the pricing of an underwritten public offering of 40,000,000 shares of its common stock, together with warrants to purchase up to an aggregate of 30,000,000...

October 18, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced that it has priced an underwritten public offering of an aggregate of 10,000,000 shares of its Common Stock, at a price to the...

October 18, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced treatment of the fifth patient, the second in the second patient cohort, in its U.S....

October 18, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic: (OSE:DIAG) Presentation of results for third quarter 2012 will take place on Wednesday 24 October 2012 at 09:00 (Norwegian time), and not on Tuesday 30 October 2012 as per earlier...

October 18, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) today announced that it has priced an underwritten public offering of 4,000,000 shares of its common stock at a price to the public of $6.00 per share for gross proceeds of...

October 18, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) today issued the following letter to the shareholders of Geron Corporation (Nasdaq: GERN) regarding Geron’s stem cell assets: October 18, 2012 AN OPEN LETTER TO GERON SHAREHOLDERS...

October 18, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Lieff Cabraser announces that class action lawsuits have been brought on behalf of all persons who purchased or acquired the securities of Questcor between April 4, 2011 and September 21, 2012.

October 18, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the third quarter on Thursday, Oct. 25, 2012...

October 18, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM, a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced today that it will be attending and hosting a scientific symposium...

October 18, 2012

WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) announced that the U.S. Food and Drug Administration (FDA) has extended the initial PDUFA date for its review of the New Drug Application (NDA) for the marketing approval of BG-12 (...

October 18, 2012

--(BUSINESS WIRE)--Sanovas, Inc.:   WHO: Dr. Stephen C. Schimpff, physician, educator, scientist, hospital CEO, cancer researcher and author   Students, researchers, consumers, medical professionals, health care executives, patients and others...

October 18, 2012

FRAZER, Pa.--(BUSINESS WIRE)--Teva Women’s Health, Inc., a U.S.-based subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), today announced new reproductive health data that will be featured at the 68th Annual Meeting of the American...

October 18, 2012

DORCHESTER, Mass.--(BUSINESS WIRE)--Biogen Idec CEO Dr. George A. Scangos to be presented with The Boston Home's "Excellence in Care Award" at November 15 Innovation and Inspiration Gala in Boston.

October 18, 2012

FARMINGTON, Conn.--(BUSINESS WIRE)--Potential clinical, practice and economic ramifications of changes in LDCT screening practices. Insight on emerging recommendations, establishment of a screening program, and coverage changes.

October 18, 2012

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its third-quarter 2012 financial results after the close of the market on Monday, October 29, 2012. The company plans to hold a...

October 18, 2012

RICHMOND, Va. & COLWORTH, England--(BUSINESS WIRE)--AmpliPhi presents data on P. aeruginosa at the NACFC showing that AmpliPhi’s mix of bacteriophage can clear lung infection.

October 18, 2012

RESEARCH TRIANGLE PARK, N.C. & SAN FRANCISCO--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) and privately held Presidio Pharmaceuticals, Inc. today announced that the companies have signed a definitive merger agreement for...

October 18, 2012

BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced the appointment of Richard J. Rubino...

October 18, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today reported third quarter net income of $583 million, or $1.06 per diluted share. This compares to net income in the same period last year of $576 million, or $1.01 per...

October 18, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced results for the quarter ended September 30, 2012. Third Quarter Results Net earnings were $148.0 million and earnings per diluted...

October 18, 2012

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Third quarter of 2012 • NET SALES amounted to MSEK 20.8 (21.9). • OPERATING PROFIT totalled MSEK 4.0 (5.5). • PROFIT AFTER TAX amounted to MSEK 2.9 (4.5). • PROFIT AFTER TAX PER SHARE was SEK 0.32 (...

October 18, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Prepares Term Sheet to Present to Amarantus

October 18, 2012

LONDON--(BUSINESS WIRE)--New report reveals urgent need for support and psychological care for psoriasis patients; as many as one third experience depression and anxiety

October 18, 2012

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: BioInvent (STO:BINV): New focus The company has decided to focus the business with the goal of achieving self-financing of operations before external costs for new clinical trials. Proprietary...

October 18, 2012

PLEASANTON, Calif.--(BUSINESS WIRE)--Veeva Systems announces today that Vault eTMF, the first electronic trial master file (eTMF) solution developed from the ground up as a multitenant cloud-based service, is now generally available. With full...

October 17, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, announced today the pricing of its previously announced underwritten public offering. CytRx is offering...

October 17, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced today that new findings regarding arterial calcification will be unveiled at the 2012 TCT conference.

October 17, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceticals has terminated its proposed convertible preferred stock offering because of current market conditions.